Inozyme Pharma Inc (INZY)
3.42
-0.13
(-3.66%)
USD |
NASDAQ |
Nov 14, 16:00
3.42
0.00 (0.00%)
After-Hours: 16:51
Inozyme Pharma Market Cap: 219.70M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 228.05M |
| November 12, 2024 | 241.54M |
| November 11, 2024 | 256.96M |
| November 08, 2024 | 258.25M |
| November 07, 2024 | 263.38M |
| November 06, 2024 | 271.74M |
| November 05, 2024 | 261.46M |
| November 04, 2024 | 283.94M |
| November 01, 2024 | 280.09M |
| October 31, 2024 | 275.59M |
| October 30, 2024 | 291.65M |
| October 29, 2024 | 296.79M |
| October 28, 2024 | 306.78M |
| October 25, 2024 | 307.42M |
| October 24, 2024 | 315.12M |
| October 23, 2024 | 314.48M |
| October 22, 2024 | 327.96M |
| October 21, 2024 | 338.87M |
| October 18, 2024 | 355.55M |
| October 17, 2024 | 330.52M |
| October 16, 2024 | 340.79M |
| October 15, 2024 | 344.64M |
| October 14, 2024 | 336.94M |
| October 11, 2024 | 332.45M |
| October 10, 2024 | 316.40M |
| Date | Value |
|---|---|
| October 09, 2024 | 327.96M |
| October 08, 2024 | 336.94M |
| October 07, 2024 | 335.01M |
| October 04, 2024 | 331.81M |
| October 03, 2024 | 324.75M |
| October 02, 2024 | 322.82M |
| October 01, 2024 | 322.18M |
| September 30, 2024 | 335.66M |
| September 27, 2024 | 347.57M |
| September 26, 2024 | 344.89M |
| September 25, 2024 | 345.56M |
| September 24, 2024 | 350.93M |
| September 23, 2024 | 352.27M |
| September 20, 2024 | 384.48M |
| September 19, 2024 | 387.83M |
| September 18, 2024 | 389.84M |
| September 17, 2024 | 391.19M |
| September 16, 2024 | 401.92M |
| September 13, 2024 | 402.59M |
| September 12, 2024 | 377.10M |
| September 11, 2024 | 349.58M |
| September 10, 2024 | 352.94M |
| September 09, 2024 | 344.22M |
| September 06, 2024 | 334.15M |
| September 05, 2024 | 350.26M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
42.41M
Minimum
Dec 30 2022
705.62M
Maximum
Sep 01 2020
290.61M
Average
275.24M
Median
Market Cap Benchmarks
| Tango Therapeutics Inc | 418.93M |
| CEL-SCI Corp | 34.44M |
| AIM ImmunoTech Inc | 16.59M |
| IGC Pharma Inc | 26.62M |
| NovaBay Pharmaceuticals Inc | 3.555M |
Market Cap Related Metrics
| Price to Book Value | 2.654 |
| Price | 3.42 |
| Earnings Yield | -45.61% |